- Home
- OGN vs CLDX Comparison
OGN vs CLDX Comparison
Compare OGN & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OGN | CLDX |
|---|---|---|
| Founded | 1923 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | OGN | CLDX |
|---|---|---|
| Price | $7.88 | $24.69 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $14.10 | ★ $41.56 |
| AVG Volume (30 Days) | ★ 6.2M | 661.2K |
| Earning Date | 02-12-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.91 | N/A |
| Revenue | ★ $6,301,000,000.00 | $2,599,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23.23 |
| P/E Ratio | $4.14 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.18 | $14.40 |
| 52 Week High | $17.23 | $30.50 |
Technical Indicators
Market Signals| Indicator | OGN | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 41.94 | 46.54 |
| Support Level | $7.74 | $22.33 |
| Resistance Level | $8.48 | $25.60 |
| Average True Range (ATR) | 0.42 | 1.21 |
| MACD | -0.17 | -0.08 |
| Stochastic Oscillator | 6.59 | 51.08 |
Price Performance
Historical ComparisonAbout OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.